Amgen Inc. (AMGN)

Statement of Cash Flows
Quarterly Data

Difficulty: Beginner

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Amgen Inc., Consolidated Statement of Cash Flows (quarterly data)

USD $ in millions

	3 months ended	Mar 31, 2019		Dec 31, 2018		Sep 30, 2018		Jun 30, 2018		Mar 31, 2018		Dec 31, 2017		Sep 30, 2017		Jun 30, 2017		Mar 31, 2017		Dec 31, 2016		Sep 30, 2016		Jun 30, 2016		Mar 31, 2016		Dec 31, 2015		Sep 30, 2015		Jun 30, 2015		Mar 31, 2015		Dec 31, 2014		Sep 30, 2014		Jun 30, 2014		Mar 31, 2014
	Net income
	Depreciation, amortization and other
	Stock-based compensation expense
	Deferred income taxes
	Other items, net
	Trade receivables, net
	Inventories
	Other assets
	Accounts payable
	Accrued income taxes, net
	Long-term tax liabilities
	Other liabilities
	Changes in operating assets and liabilities, net of acquisitions
	Net cash provided by operating activities
	Purchases of marketable securities
	Proceeds from sales of marketable securities
	Proceeds from maturities of marketable securities
	Cash paid for acquisitions, net of cash acquired
	Purchases of property, plant and equipment
	Change in restricted investments
	Other
	Net cash (used in) provided by investing activities
	Net proceeds from issuance of debt
	Repayment of debt
	Net change in commercial paper
	Repurchases of common stock
	Dividends paid
	Settlement of contingent consideration obligation
	Other
	Net cash provided by (used in) financing activities
	Increase (decrease) in cash and cash equivalents

Item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Amgen Inc.’s net cash provided by operating activities declined from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.
Net cash (used in) provided by investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Amgen Inc.’s net cash (used in) provided by investing activities declined from Q3 2018 to Q4 2018 but then increased from Q4 2018 to Q1 2019 exceeding Q3 2018 level.
Net cash provided by (used in) financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Amgen Inc.’s net cash provided by (used in) financing activities declined from Q3 2018 to Q4 2018 and from Q4 2018 to Q1 2019.

	Amgen Inc.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

Amgen Inc. (AMGN)

Statement of Cash FlowsQuarterly Data

Statement of Cash Flows
Quarterly Data